跳至主要内容
临床试验/ACTRN12616000276459
ACTRN12616000276459已完成2 期

Efficacy of ascorbic acid in improving glycaemic control in type 2 diabetes

Dr Glenn Wadley0 个研究点目标入组 29 人开始时间: 2016年3月2日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
29

研究概览

简要总结

The main aim of this study was to investigate whether ascorbic acid (AA) supplementation improves glycaemic control under free-living conditions in individuals with type 2 diabetes. We also investigated effects of AA supplementation on blood pressure. Thirty-one individuals with type 2 diabetes (26 males and 5 females; average age 62 years; average duration of diabetes 5.6 years) and moderate glucose control (average HbA1c 7.6%) were enrolled in a randomized cross-over study involving 4 months of supplementation with oral AA (2 × 500 mg/day) or placebo. Participants took both AA and placebo, however the order of each 4-month period was randomized and blinded to both participants and researchers. AA supplementation significantly decreased the average daily post-meal glucose response, the duration of day spent in hyperglycaemia, the average 24-hour glucose concentration, blood pressure, and a marker of oxidative stress in blood as compared to placebo. Overall, individuals with type 2 diabetes experienced improved post-meal and 24-hour glucose levels and decreased blood pressure after 4 months of AA supplementation as compared to placebo. These findings offer evidence for the proposed use of AA as an adjunct therapy to improve glycaemic and blood pressure control in individuals with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
All

入选标准

  • (i) Type 2 diabetes with glycaemic control that is modest (HbA1c between 7.0% and 9.0%); (ii) aged 45-75 years; (iii) body mass index < 35 kg/m2; (iv) blood pressure <160/90 mmHg.

排除标准

  • (i) Having a major medical illness in addition to Type 2 diabetes; (ii) taking >2000 mg metformin per day) or more than 2 different diabetes medications or on insulin therapy; (iii) smokers; (iv) taking vitamin supplements other than those provided by us during the trial

研究者

发起方
Dr Glenn Wadley

相似试验